Ninth Circuit Upholds FDA’s Authority to Regulate Stem Cell Clinic Treatments
FDA Law Blog
OCTOBER 14, 2024
These procedures are offered to treat a variety of conditions, including Alzheimer’s, arthritis, asthma, cancer, etc., The lowest risk category, which is not subject to any oversight by FDA, includes HCT/Ps removed from an individual that are implanted into the same individual during the “same surgical procedure.” 21 U.S.C. §
59 
Let's personalize your content